Disruption of the GH receptor gene in adult mice increases maximal lifespan in females

Endocrinology

Volumn 157, Issue 12, 2016, Pages 4502-4513

  Junnila, Riia K ^a   Duran Ortiz, Silvana ^a   Suer, Ozan ^a   Sustarsic, Elahu G ^a   Berryman, Darlene E ^a,b   List, Edward O ^a   Kopchick, John J ^a,b  

^a OHIO UNIVERSITY   (United States)

^b OHIO UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADIPONECTIN; GLUCOSE; GROWTH HORMONE; GROWTH HORMONE RECEPTOR; INSULIN; INTERLEUKIN 6; MONOCYTE CHEMOTACTIC PROTEIN 1; RESISTIN; SOMATOMEDIN C; TRIACYLGLYCEROL;

ADULT; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; FEMALE; GENE DELETION; GENE DISRUPTION; GENE EXPRESSION; GENE INACTIVATION; GLUCOSE TOLERANCE; GROWTH HORMONE BLOOD LEVEL; GROWTH RETARDATION; INSULIN SENSITIVITY; LIFE EXTENSION; MALE; MOUSE; NONHUMAN; OBESITY; PRIORITY JOURNAL; ANIMAL; BLOOD; GENETICS; INSULIN RESISTANCE; KNOCKOUT MOUSE; LONGEVITY; METABOLISM; SEX DIFFERENCE; SIGNAL TRANSDUCTION;

ADIPOSITY; ANIMALS; FEMALE; GROWTH HORMONE; INSULIN RESISTANCE; INSULIN-LIKE GROWTH FACTOR I; LONGEVITY; MALE; MICE; MICE, KNOCKOUT; RECEPTORS, SOMATOTROPIN; SEX FACTORS; SIGNAL TRANSDUCTION;

EID: 85002497839     PISSN: 00137227     EISSN: 19457170     Source Type: Journal    
DOI: 10.1210/en.2016-1649     Document Type: Article

References (56)

1. Fontana L, Partridge L, Longo VD. Extending healthy life span-from yeast to humans. Science. 2010;328(5976):321-326.
2. Møller N, Jørgensen JO. Effects of growth hormone on glucose, lipid, and protein metabolism in human subjects. Endocr Rev. 2009; 30(2):152-177.
3. Lupu F, Terwilliger JD, Lee K, Segre GV, Efstratiadis A. Roles of growth hormone and insulin-like growth factor 1 in mouse postnatal growth. Dev Biol. 2001;229(1):141-162.
4. Junnila RK, List EO, Berryman DE, Murrey JW, Kopchick JJ. The GH/IGF-1 axis in ageing and longevity. Nat Rev Endocrinol. 2013; 9(6):366-376.
5. Coschigano KT, Holland AN, Riders ME, List EO, Flyvbjerg A, Kopchick JJ. Deletion, but not antagonism, of the mouse growth hormone receptor results in severely decreased body weights, insulin, and insulin-like growth factor I levels and increased life span. Endocrinology. 2003;144(9):3799-3810.
6. Pilcher H. Money for old mice (online). Nat News. September 22, 2003.
7. Ikeno Y, Hubbard GB, Lee S, et al. Reduced incidence and delayed occurrence of fatal neoplastic diseases in growth hormone receptor/ binding protein knockout mice. J GerontolABiol SciMedSci. 2009; 64(5):522-529.
8. Majeed N, Blouin MJ, Kaplan-Lefko PJ, et al. A germ line mutation that delays prostate cancer progression and prolongs survival in a murine prostate cancer model. Oncogene. 2005;24(29):4736-4740.
9. Pollak M, Blouin MJ, Zhang JC, Kopchick JJ. Reduced mammary gland carcinogenesis in transgenic mice expressing a growth hormone antagonist. Br J Cancer. 2001;85(3):428-430.
10. Laron Z, Pertzelan A, Mannheimer S. Genetic pituitary dwarfism with high serum concentation of growth hormone-a new inborn error of metabolism? Isr J Med Sci. 1966;2(2):152-155.
11. Laron Z, Kauli R. Fifty seven years of follow-up of the Israeli cohort of Laron syndrome patients-from discovery to treatment. Growth Horm IGF Res. 2016;28:53-56.
12. Guevara-Aguirre J, Balasubramanian P, Guevara-Aguirre M, et al. Growth hormone receptor deficiency is associated with a major reduction in pro-aging signaling, cancer, and diabetes in humans. Sci Transl Med. 2011;3(70):70ra13.
13. Aguiar-Oliveira MH, Oliveira FT, Pereira RM, et al. Longevity in untreated congenital growth hormone deficiency due to a homozygous mutation in the GHRH receptor gene. J Clin Endocrinol Metab. 2010;95(2):714-721.
14. Krzisnik C, Grgurić S, Cvijović K, Laron Z. Longevity of the hypopituitary patients from the island Krk: a follow-up study. Pediatr Endocrinol Rev. 2010;7(4):357-362.
15. Cook DM, Yuen KC, Biller BM, Kemp SF, Vance ML, American Association of Clinical Endocrinologists. American Association of Clinical Endocrinologists medical guidelines for clinical practice for growth hormone use in growth hormone-deficient adults and transition patients-2009 update. Endocr Pract. 2009;15(suppl 2):1-29.
16. Stochholm K, Gravholt CH, Laursen T, et al. Mortality and GH deficiency: a nationwide study. Eur J Endocrinol. 2007;157(1): 9-18.
17. Ayuk J, Sheppard MC. Does acromegaly enhance mortality? Rev Endocr Metab Disord. 2008;9(1):33-39.
18. Ben-Shlomo A, Sheppard MC, Stephens JM, Pulgar S, Melmed S. Clinical, quality of life, and economic value of acromegaly disease control. Pituitary. 2011;14(3):284-294.
19. Bartke A. Can growth hormone (GH) accelerate aging? Evidence from GH-transgenic mice. Neuroendocrinology. 2003;78(4):210-216.
20. List EO, Berryman DE, Funk K, et al. The role of GH in adipose tissue: lessons from adipose-specific GH receptor gene-disrupted mice. Mol Endocrinol. 2013;27(3):524-535.
21. List EO, Berryman DE, Funk K, et al. Liver-specific GH receptor gene-disrupted (LiGHRKO) mice have decreased endocrine IGF-I, increased local IGF-I, and altered body size, body composition, and adipokine profiles. Endocrinology. 2014;155(5):1793-1805.
22. Ventura A, Kirsch DG, McLaughlin ME, et al. Restoration of p53 function leads to tumour regression in vivo. Nature. 2007; 445(7128):661-665.
23. Friedrich G, Soriano P. Promoter traps in embryonic stem cells: a genetic screen to identify and mutate developmental genes in mice. Genes Dev. 1991;5(9):1513-1523.
24. Zambrowicz BP, Imamoto A, Fiering S, Herzenberg LA, Kerr WG, Soriano P. Disruption of overlapping transcripts in the ROSA geo 26 gene trap strain leads to widespread expression of galactosidase in mouse embryos and hematopoietic cells. Proc Natl Acad Sci USA. 1997;94(8):3789-3794.
25. Jara A, Liu X, Sim D, et al. Cardiac-specific disruption of GH receptor alters glucose homeostasis while maintaining normal cardiac performance in adult male mice. Endocrinology. 2016;157(5): 1929-1941.
26. Feil S, Valtcheva N, Feil R. Inducible Cre mice. Methods Mol Biol. 2009;530:343-363.
27. Berryman DE, List EO, Palmer AJ, et al. Two-year body composition analyses of long-livedGHRnull mice. J GerontolABiol SciMed Sci. 2010;65(1):31-40.
28. List EO, Berryman DE, Ikeno Y, et al. Removal of growth hormone receptor (GHR) in muscle of male mice replicates some of the health benefits seen in global GHR-/ mice. Aging. 2015;7(7):500-512.
29. Sustarsic EG, Junnila RK, Kopchick JJ. Human metastatic melanoma cell lines express high levels of growth hormone receptor and respond to GH treatment. Biochem Biophys Res Commun. 2013; 441(1):144-150.
30. Comisford R, Lubbers ER, Householder LA, et al. Growth hormone receptor antagonist transgenic mice have increased subcutaneous adipose tissue mass, altered glucose homeostasis and no change in white adipose tissue cellular senescence. Gerontology. 2016;62(2): 163-172.
31. Salmon DM, Flatt JP. Effect of dietary fat content on the incidence of obesity among ad libitum fed mice. Int J Obes. 1985;9(6):443-449.
32. Wang C, Li Q, Redden DT, Weindruch R, Allison DB. Statistical methods for testing effects on maximum lifespan. Mech Ageing Dev. 2004;125(9):629-632
33. Fan Y, Menon RK, Cohen P, et al. Liver-specific deletion of the growth hormone receptor reveals essential role of growth hormone signaling in hepatic lipid metabolism. J Biol Chem. 2009;284(30): 19937-19944.
34. Sjögren K, Liu JL, Blad K, et al. Liver-derived insulin-like growth factor I (IGF-I) is the principal source of IGF-I in blood but is not required for postnatal body growth in mice. Proc Natl Acad SciUSA. 1999;96(12):7088-7092.
35. Yakar S, Liu JL, Stannard B, et al. Normal growth and development in the absence of hepatic insulin-like growth factor I. Proc Natl Acad Sci USA. 1999;96(13):7324-7329.
36. Liu JL, Coschigano KT, Robertson K, et al. Disruption of growth hormone receptor gene causes diminished pancreatic islet size and increased insulin sensitivity in mice. Am J Physiol Endocrinol Metab. 2004;287(3):E405-E413.
37. Guo Y, Lu Y, Houle D, et al. Pancreatic islet-specific expression of an insulin-like growth factor-I transgene compensates islet cell growth in growth hormone receptor gene-deficient mice. Endocrinology. 2005;146(6):2602-2609.
38. Berryman DE, Lubbers ER,MagonV, ListEO,Kopchick JJ. Adwarf mouse model with decreased GH/IGF-1 activity that does not experience life-span extension: potential impact of increased adiposity, leptin, and insulin with advancing age. J GerontolABiol SciMedSci. 2014;69(2):131-141.
39. List EO, Sackmann-Sala L, Berryman DE, et al. Endocrine parameters and phenotypes of the growth hormone receptor gene disrupted (GHR-/-) mouse. Endocr Rev. 2011;32(3):356-386.
40. Houssay BA. The hypophysis and metabolism. NEngl J Med. 1936; 214(20):961-971.
41. WuY, Liu C, Sun H, et al. Growth hormone receptor regulates cell hyperplasia and glucose-stimulated insulin secretion in obese mice. J Clin Invest. 2011;121(6):2422-2426.
42. Ma F, Wei Z, Shi C, et al. Signaling cross talk between growth hormone (GH) and insulin-like growth factor-I (IGF-I) in pancreatic islet cells. Mol Endocrinol. 2011;25(12):2119-2133.
43. Cordoba-Chacon J, Gahete MD, Pokala NK, et al. Long-but not short-term adult-onset, isolatedGHdeficiency in male mice leads to deterioration of cell function, which cannot be accounted for by changes in cell mass. Endocrinology. 2014;155(3):726-735.
44. Luque RM, Lin Q, Córdoba-Chacón J, et al. Metabolic impact of adult-onset, isolated, growth hormone deficiency (AOiGHD) due to destruction of pituitary somatotropes. PLoS One. 2011;6(1): e15767.
45. Svensson J, Sjögren K, Fäldt J, et al. Liver-derived IGF-I regulates mean life span in mice. PLoS One. 2011;6(7):e22640.
46. Holzenberger M, Dupont J, Ducos B, et al. IGF-1 receptor regulates lifespan and resistance to oxidative stress in mice. Nature. 2003; 421(6919):182-187.
47. Hoeflich A, Reyer A, Ohde D, et al. Dissociation of somatic growth, time of sexual maturity, and life expectancy by overexpression of an RGD-deficient IGFBP-2 variant in female transgenic mice. Aging Cell. 2016;15(1):111-117.
48. Suh Y, Atzmon G, Cho MO, et al. Functionally significant insulinlike growth factor I receptor mutations in centenarians. Proc Natl Acad Sci USA. 2008;105(9):3438-3442.
49. Tran TT, Yamamoto Y, Gesta S, Kahn CR. Beneficial effects of subcutaneous fat transplantation on metabolism. Cell Metab. 2008; 7(5):410-420.
50. Berryman DE, List EO, Sackmann-Sala L, Lubbers E, Munn R, Kopchick JJ. Growth hormone and adipose tissue: beyond the adipocyte. Growth Horm IGF Res. 2011;21(3):113-123.
51. McKeeAlderman J, DePetrilloMA,GluesenkampAM,et al. Calorie restriction and dwarf mice in gerontological research. Gerontology. 2010;56(4):404-409.
52. Chang I, Bramall AN, Baynash AG, et al. Endothelin-2 deficiency causes growth retardation, hypothermia, and emphysema in mice. J Clin Invest. 2013;123(6):2643-2653.
53. Brower CS, Varshavsky A. Ablation of arginylation in the mouse N-end rule pathway: loss of fat, higher metabolic rate, damaged spermatogenesis, and neurological perturbations. PLoS One. 2009; 4(11):e7757.
54. Doherty HE, Kim HS, Hiller S, Sulik KK, Maeda N. A mouse strain where basal connective tissue growth factor gene expression can be switched from low to high. PLoS One. 2010;5(9):e12909.
55. Hathaway CK, Grant R, Hagaman JR, et al. Endothelin-1 critically influences cardiac function via superoxide-MMP9 cascade. Proc Natl Acad Sci USA. 2015;112(16):5141-5146.
56. de Renty C, Kaneko KJ, DePamphilis ML. The dual roles of geminin during trophoblast proliferation and differentiation. Dev Biol. 2014;387(1):49-63.